26/11/2009 10:11:06

- Icelandair Group sells 20% of its share in the Czech airline Travel Service.

Yesterday Icelandair Group signed an agreement regarding the sale of 20% of its

share in the Czech airline, Travel Service. After the transaction Icelandair

Group holds a 30% share in Travel Service. The acquirer is Canaria Travel,

which is under the same ownership as Icelandair Group's co-owners in Travel

Service.

After the sale Travel Service becomes an affiliated company instead of being a

subsidiary. The effects of the sale on the income statement are negative by

ISK 0.9 billion and equity decreases by ISK 1.5 billion. The Group‘s total

assets decrease by ISK 12 billion. With this sale Icelandair Group will not

participate in the financing of Travel Service's expansion.

Björgólfur Jóhannsson, CEO of Icelandair Group:

“As an Icelandic company with balance sheet that is being restructured, it is

difficult to support the financing of our foreign subsidiaries. Effectively,

our majority holding has affected the company‘s bank relations in the Czech

Republic. Travel Service is a solid company and has returned good operating

results, however it is foreseen that it‘s operating environment in the near

future will be challenging. It is considered beneficial for both companies to

sell our co-owners in the Czech Republic 20% of the shares, thus they become a

majority shareholder in Travel Service”.

For further information contact:

Björgólfur Jóhansson, CEO of Icelandair Group Tel: 354-896-1455

Bogi Nils Bogason, CFO of Icelandair Group Tel: 354-665-8801

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
21 Jul
FING-B
Du er overalt. Du skriver i Fingersprint trådene og opretter derefter ny tråd med samme indhold. Nu ..
39
19 Jul
GEN
Ja, det ligner simpelthen ingenting. Siden starten af 2012 er Genmab under ledelse af Jan W. kun ste..
24
17 Jul
VELO
Med den status som Envarsus har bør der kunne komme gang i salget ret hurtigt. Et bud kan være inden..
14
19 Jul
PNDORA
Alle disse Pandora tråde uden substans lugter langt væk af desperation.
12
20 Jul
 
Et kæmpe tab. En sindsyg dygtig, højt respekteret og solid klippe af "sund fornuft" som igennem mang..
11
18 Jul
VELO
  Den kinesiske pendant til amerikanske FDA, er i foråret 2017 begyndt og tilbyder forhåndsgodkendel..
11
17 Jul
 
Mange ting er allerede sagt, men:   1. Vær klar over, at du kommer til at skulle bruge tusindevis af..
11
19 Jul
PNDORA
Jeg synes begge sider burde erkende, at ingen af dem eller ingen i det hele taget i hele verden, hve..
10
15 Jul
PNDORA
Ja der er store kræfter der leger med, de store kræfter er vist ligeglad med teknisk analyse, så ned..
10
20 Jul
PNDORA
Den øjeblikkelige kurs omkring 700 afspejler fortsat negative forventninger, der delvist blev indfri..
9

Man Group PLC : Form 8.3 - [Monitise PLC]

21/07/2017 12:57:03
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Man Group Plc (b) Owner or controller..

Mothercare Plc : Director/PDMR Shareholding

21/07/2017 10:16:06
21 July 2017 Mothercare plc  Director/PDMR shareholdings Mothercare plc has received notification of the following transaction in its ordinary shares.  In accordance with Article 19 of the EU Market Abuse Regulation, the relevant FCA notification is set out below.   Following the transaction, the total beneficial interest in the Company held by Mr Newton-Jones is 363,972 ordinar..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Stull, Stull & Brody Announces Class Action Lawsuit on Behalf of Employee Benefit Plan Purchasers of American Depository Shares of Teva Pharmaceutical Industries Limited
2
First Savings Financial Group, Inc. and The First National Bank of Odon Sign Definitive Acquisition Agreement
3
Lodes Chiropractic Center Educates Patients on Chiropractic Care for Runners
4
Veterinary Wellness Center of Boerum Hill Announces Special on its Basic Vaccine Package
5
Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 July 2017 09:35:10
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170720.2 - EUROWEB5 - 2017-07-22 10:35:10 - 2017-07-22 09:35:10 - 1000 - Website: OKAY